Crysalin
Crysalin Ltd was founded in June of 2007 in order to research, develop and license crysalin lattice technology - a new area of protein-based nanotechnology. The technology is founded upon patented research conducted since 2002 in the Oxford University Laboratory of Molecular Biophysics.
Crysalin lattice design principles allow for tailored crystal formation in 1-, 2- and 3- dimensions with repeating units on scales of approximately 1-100nm. Application of these techniques will allow the determination of the structures of currently intractable molecules such as membrane proteins and other insoluble biomolecules.
The company will make money by providing services for structure based drug discovery, and potentially by selling high value research reagents and licensing its technologies for use in other applications in markets outside its core focus.